AI assistant
DAVITA INC. — Director's Dealing 2016
Apr 12, 2016
30643_dirs_2016-04-12_e09a4c6f-b1b8-4650-8f31-3d1e1dfb4512.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2016-04-11
Reporting Person: Rodriguez Javier (CEO-Kidney Care)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-04-11 | Common Stock | M | 216667 | $43.35 | Acquired | 317397 | Direct |
| 2016-04-11 | Common Stock | F | 126755 | $74.10 | Disposed | 190642 | Direct |
| 2016-04-11 | Common Stock | S | 89912 | $73.5063 | Disposed | 100730 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-04-11 | Stock Appreciation Rights | $43.35 | M | 216667 | Disposed | 2016-04-13 | Common Stock (216667) | Direct |
Footnotes
F1: The exercise and sale reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2015.
F2: Represents the weighted average sale price of $73.5063. The range of prices for the sale of these shares was $73.24-$74.29, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F3: The Stock Appreciation Rights were granted on 4/13/2011. 50% vested on 4/13/2014 and the remaining 50% vested on 4/13/2015.